Table 2 Baseline characteristics of the participants included in the PREVAC trial
Version 2.0 | Version 3.0 | Version 4.0 | All versions | |||||
|---|---|---|---|---|---|---|---|---|
No. | Pct. | No. | Pct. | No. | Pct. | No. | Pct. | |
Country | ||||||||
Guinea | 263 | 49.0 | 1068 | 73.7 | 999 | 35.7 | 2330 | 48.7 |
Liberia | 274 | 51.0 | 382 | 26.3 | 477 | 17.0 | 1133 | 23.7 |
Sierra Leone | 0 | 0.0 | 0 | 0.0 | 708 | 25.3 | 708 | 14.8 |
Mali | 0 | 0.0 | 0 | 0.0 | 618 | 22.1 | 618 | 12.9 |
Gender | ||||||||
Male | 333 | 62.0 | 743 | 51.2 | 1536 | 54.8 | 2612 | 54.5 |
Female | 204 | 38.0 | 707 | 48.8 | 1266 | 45.2 | 2177 | 45.5 |
Age | ||||||||
1–4 years | 0 | 0.0 | 82 | 5.7 | 467 | 16.7 | 549 | 11.5 |
5–11 years | 0 | 0.0 | 283 | 19.5 | 467 | 16.7 | 750 | 15.7 |
12–17 years | 41 | 7.6 | 422 | 29.1 | 467 | 16.7 | 930 | 19.4 |
18–34 years | 354 | 65.9 | 413 | 28.5 | 946 | 33.8 | 1713 | 35.8 |
35–54 years | 114 | 21.2 | 187 | 12.9 | 368 | 13.1 | 669 | 14.0 |
≥ 55 years | 28 | 5.2 | 63 | 4.3 | 87 | 3.1 | 178 | 3.7 |
Median (25th, 75th %) | 26 (20–35) | 17 (11–28) | 18 (8–27) | 18 (11–28) | ||||
Indicators of increased risk | ||||||||
Contact with case | 4 | 0.7 | 7 | 0.5 | 2 | 0.1 | 13 | 0.3 |
Work entailing contact | 3 | 0.6 | 1 | 0.1 | 1 | 0.1 | 5 | 0.1 |
Clinical examination Median (25th, 75th %) | ||||||||
Weight (kg) | 64 (57–71) | 54 (33–65) | 52 (25–63) | 54 (31–65) | ||||
Height (cm) | 167 (160–173) | 159 (143–168) | 158 (128–168) | 160 (140–169) | ||||
BMI* | 22.4 (20.4–25.4) | 20.2 (17.1–23.6) | 20.5 (17.2–23.6) | 20.7 (17.6–23.8) | ||||
Arm circumference** (cm) | 15.8 (15.0–16.4) | 15.5 (14.6–16.2) | 15.5 (14.6–16.2) | |||||
Body temperature (o C) | 36.5 (36.4–36.7) | 36.5 (36.4–36.7) | 36.6 (36.4–36.8) | 36.6 (36.4–36.8) | ||||
Infection test results | ||||||||
HIV positive | 14 | 2.6 | 15 | 1.0 | 25 | 0.9 | 54 | 1.1 |
Syphilis positive | 11 | 2.0 | 16 | 1.1 | 18 | 0.6 | 45 | 0.9 |
No. enrolled | 537 | 1450 | 2802 | 4789 | ||||